Is Benefitfocus (NASDAQ:BNFT) A Risky Investment?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We note that Benefitfocus, Inc. (NASDAQ:BNFT) does have debt on its balance sheet. But the more important question is: how much risk is that debt creating?

Advertisement

When Is Debt A Problem?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. However, a more frequent (but still costly) occurrence is where a company must issue shares at bargain-basement prices, permanently diluting shareholders, just to shore up its balance sheet. Of course, plenty of companies use debt to fund growth, without any negative consequences. The first thing to do when considering how much debt a business uses is to look at its cash and debt together.

See our latest analysis for Benefitfocus

What Is Benefitfocus's Net Debt?

As you can see below, at the end of June 2019, Benefitfocus had US$183.7m of debt, up from US$128.4m a year ago. Click the image for more detail. However, it also had US$138.4m in cash, and so its net debt is US$45.3m.

NasdaqGM:BNFT Historical Debt, August 12th 2019
NasdaqGM:BNFT Historical Debt, August 12th 2019

How Healthy Is Benefitfocus's Balance Sheet?

We can see from the most recent balance sheet that Benefitfocus had liabilities of US$74.4m falling due within a year, and liabilities of US$279.9m due beyond that. Offsetting these obligations, it had cash of US$138.4m as well as receivables valued at US$42.5m due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$173.4m.

Benefitfocus has a market capitalization of US$862.9m, so it could very likely raise cash to ameliorate its balance sheet, if the need arose. However, it is still worthwhile taking a close look at its ability to pay off debt. When analysing debt levels, the balance sheet is the obvious place to start. But it is future earnings, more than anything, that will determine Benefitfocus's ability to maintain a healthy balance sheet going forward. So if you're focused on the future you can check out this free report showing analyst profit forecasts.

Over 12 months, Benefitfocus reported revenue of US$273m, which is a gain of 10%. We usually like to see faster growth from unprofitable companies, but each to their own.

Caveat Emptor

Importantly, Benefitfocus had negative earnings before interest and tax (EBIT), over the last year. Indeed, it lost US$36m at the EBIT level. When we look at that and recall the liabilities on its balance sheet, relative to cash, it seems unwise to us for the company to have any debt. So we think its balance sheet is a little strained, though not beyond repair. Another cause for caution is that is bled US$19m in negative free cash flow over the last twelve months. So suffice it to say we do consider the stock to be risky. When I consider a company to be a bit risky, I think it is responsible to check out whether insiders have been reporting any share sales. Luckily, you can click here ito see our graphic depicting Benefitfocus insider transactions.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

Is Nvidia actually expensive at 32 times earnings? I think that number can melt faster than people realise.

Is Nvidia actually expensive at 32 times earnings? I think that number can melt faster than people realise. cover
77
MA
marcus_l38oa

Why would I fret over Nvidia results now? I think it's moment has gone. I will invert and see what companies can be the next Nvidia.

SE
sean_3pk06

Multiple has already melted 50 percent in the last year. It can melt another 50 percent from here in the next year?

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
42

About NasdaqGM:BNFT

Benefitfocus

Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States.

Slightly overvalued with imperfect balance sheet.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$522.8% undervalued
69 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.7% undervalued
52 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
47 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11630.7% undervalued
12 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

AS
AstrisCorporateAdvisory
3156 logo
AstrisCorporateAdvisory on Restar ·

Monitoring next steps

Fair Value:JP¥2.59k96.7% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
prajeeshprathap
MEDP logo
prajeeshprathap on Medpace Holdings ·

Why Medpace Outperforms Competitors in the Mid-Sized Biotech Niche

Fair Value:US$53614.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
3010 logo
AstrisCorporateAdvisory on Polaris Holdings ·

Share gains to fuel earnings momentum

Fair Value:JP¥211.168.6% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.9% undervalued
359 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9117.1% overvalued
206 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.1% undervalued
231 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0
AL
BUSER logo
AlfredB on Bambuser ·

Very Intresting Times for Bambuser

1
|
0